Oral administration of verapamil reduced TXNIP expression and β-cell apoptosis, enhanced endogenous insulin levels, protected BTBR ob/ob mice as a model of T2D and mice from streptozotocin-induced diabetes (73). Here, TXNIP is linked to type 2 diabetes mellitus.